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Most phases of the drug design 
process have benefited to some 
extent from new technologies. The 
early steps of computational design: 
drug target identification, initial drug 
molecule identification, and chemical 
elaboration on the lead compound 
have been significantly improved by 
advances in algorithms, large amounts 
of data and better technology. There 
are many online resources that relate 
to drug design techniques; here we 
focus on a few websites relevant to 
the ‘lead identification’ phase of the 
computational drug design process. 
Advances in biochemistry, molecular 
biology and combinatorial chemistry, 
together with new techniques such as 
high-throughput screening have had a 
dramatic impact on the field but they 
will not be covered in detail here. 
Structure-based design: protein 
structures 
Knowledge of a three- 
dimensional structure for a drug 
target can greatly facilitate the drug 
design process. A previous web alert 
(&em. Biol. 5, R149) describes a 
number of websites where protein 
structures can be obtained, the most 
important of which is the Protein 
Data Bank at the Research 
Collaboratory for Structural 
Bioinformatics (PDB-RCSB). 
Frequently, however, there is no 
known structure for a drug target. 
In these cases, homology modeling 
after the identification of a 
homologous sequence can point to 
what the structure might look like. 
A popular method for identifying 
similar protein sequences is the 
BLAST program from the National 
Center for Biotechnology 
Information (BLAST-NCBI). The 
alignment can be restricted to 
sequences found in the PDB (i.e. 
those with known structures). 
Generating homology models is an 
active area of research. Most 
prediction tools recommend 
substantial user input and 
interaction when generating the 
model. The CMS Molecular 
Biology Resource is an excellent 
index that has links to prediction 
tools and many other sites related 
to drug design. 
Structure-based design: small 
molecules 
Many drug design efforts rely on 
screening available compounds. One 
publicly available database is at the 
National Cancer Institute’s 
Web sites and URLs 
PDB-RCSB http://www.rcsb.org/ 
BLAST-NCBI http:/lwww.ncbi.nIm.nih.gov/BLAST/ 
The CMS Molecular Biology Resource http:l/www.unl.edu/stc-95/ResToolslcmshp.htmI 
Developmental Therapeutics Program http:l/dtp.nci.nih.govl 
of the National Cancer Institute 
MDL Information Systems, Inc. http:/lwww.mdli.coml 
Cambridge Crystallographic Data Centre http:l/www.ccdc.cam.ac.uW 
Daylight Chemical Information Systems, Inc. http://www.daylight.coml 
DOCK http:l/www.cmpharm.ucsf.edu/kuntz/dock.html 
FlexX http://cartan.gmd.de/flex-bin/FlexX 
AutoDock http://www.scripps.edu/pub/olson-web/doc/autodock/index.html 
Molecular Simulations, Inc. http:l/www.msi.com/downloadlindex.htmI 
UCSF MidasPlus http://www.cgl.ucsf.edulOutreach/midasplus/ 
PubMed http://www.ncbi.nlm.nih.govlPubMedl 
Institute for Scientific Information http://www.isinet.coml 
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Developmental Therapeutics 
Program (DTP-NCI). Here the 
three-dimensional structures of 
approximately 140,000 small 
molecules can be downloaded (an 
additional 240,000 are available in 
SMILES format). It is also possible 
to order some of the compounds in 
experimental quantities for testing. 
One of the largest structure- 
searchable database of commercially 
available chemicals is the Available 
Chemicals Directory from MDL 
Information Systems (ACD-MDL), 
which lists compounds commonly 
available from a number of different 
chemical companies. Another useful 
database is the Cambridge Structural 
Database (CSD), which contains the 
crystal structures of about 190,000 
small molecules. 
Small molecule databases 
Most groups attempting to screen 
large databases of compounds for 
potential drug leads try to filter out 
molecules with properties known to 
make poor drug molecules (e.g., 
those with high ClogP values). 
Daylight Chemical Information 
Systems has an online demonstration 
of products, which are also available 
for purchase, that can be used to 
calculate some of these properties. 
Although filtering databases can 
greatly reduce their size, databases 
of lOO,OOO-l,OOO,OOO compounds are 
not uncommon. It is important in 
most drug design efforts to search 
and sort through these large 
chemical databases, using both 
traditional search parameters and 
more complex features such as 
structural motifs or functional 
groups. Two popular tools 
specifically designed for organizing 
databases of small molecules include 
ISIS/Base from MDL and 
Thor/Merlin from Daylight. 
Molecular docking 
A common tool used to evaluate 
complementarity between potential 
lead molecules and their targets is 
molecular docking. A widely used 
program is DOCK, available from 
the Kuntz lab at University of 
California at San Francisco (UCSF). 
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This software can be downloaded 
and is free for academic institutions. 
The code is distributed with 
DOCK, allowing for local 
development-we use a variation 
of this program in our own research. 
Another popular molecular docking 
algorithm is FlexX. This algorithm 
can be used through a web interface 
and can be downloaded. Although 
the web is useful for demonstration 
purposes, screening compound 
databases is more efficient if you 
download and install the software, 
as most molecular docking 
calculations are CPU intensive. A 
molecular mechanics based method, 
AutoDock, available from the Olson 
lab at Scripps, is another well-tested 
algorithm. AutoDock and FlexX are 
also free for academic institutions. 
Visualization tools 
Frequently, these complex 
algorithms for evaluating 
complementarity are used as a guide 
to direct the user to better 
molecules. In our work, we have 
found that visual inspection of the 
top few hundred leads proves to be 
invaluable. There are many 
programs available for this visual 
inspection (see Chem. Biol. 6, R2.5). 
One of the best visualization tools 
for the Windows and Mac platforms 
is WebLab from Molecular 
Simulations Inc (MSI). For 
visualization on SGI workstations, 
we have found Midas from UCSF to 
be very useful. 
There are many online resources 
that can be used to help identify new 
drug leads. It is important to 
remember that traditional methods 
still contribute to the drug design 
process. In particular, scientific 
journals are increasingly filled with 
references about new techniques for 
drug design. PubMed, the large, 
publicly available database of 
medically related journals is useful 
but does not index some of the 
journals containing information 
about drug design (e.g. Journal of 
Computational Chemistry and Journal 
of the American ChemicalSociety). The 
Science Citation Index distributed 
by the Institute for Scientific 
Information (ISI) contains a broader 
list of journals related to drug design. 
Although this resource is not free, it 
is invaluable for keeping up with the 
current methods and technology. 
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